In addition to long Covid this may be another opportunity for Apabetalone. 

"Disease X represents the knowledge that a serious international epidemic could be caused by a pathogen currently unknown to cause human disease," the WHO says on its website. "The R&D (research and development) blueprint explicitly seeks to enable early cross-cutting R&D preparedness that is also relevant for an unknown 'Disease X.’"

RVX-208 being 8 years ahead of its time may be the therapeutic for this expected future pandemic.